Company · CIK 1997038

# Iambic Therapeutics, Inc.

| CIK | [1997038](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001997038) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | CA |
| Listed | IAM (Nasdaq) |
| First annual or quarterly report | none on EDGAR |

## Offerings

 1 registration

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-299057 | IPO Final prospectus | 2026-09-21 | 2026-10-15 | 4 |

## Filings

 5

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2026-10-15 | [424B4](https://www.sec.gov/Archives/edgar/data/1997038/000119312526422865/0001193125-26-422865-index.htm) Final prospectus | 333-299057 | 0001193125-26-422865 |
| 2026-10-14 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1997038/999999999526003244/9999999995-26-003244-index.htm) Declared effective | 333-299057 | 9999999995-26-003244 |
| 2026-10-08 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1997038/000119312526417416/0001193125-26-417416-index.htm) Amendment | 333-299057 | 0001193125-26-417416 |
| 2026-09-21 | [S-1](https://www.sec.gov/Archives/edgar/data/1997038/000119312526396704/0001193125-26-396704-index.htm) Registration filed | 333-299057 | 0001193125-26-396704 |
| 2026-07-24 | [DRS](https://www.sec.gov/Archives/edgar/data/1997038/000119312526315779/0001193125-26-315779-index.htm) Draft made public | 377-09598 | 0001193125-26-315779 |

[All filings of this company](https://equitycapital.markets/filings?cik=1997038) · [CSV](https://equitycapital.markets/filings.csv?cik=1997038)

---
Source page: https://equitycapital.markets/company/1997038 · Data: U.S. SEC EDGAR · CC BY 4.0